Foundation
It all began in 2012 when Nikan Pharmed (a private joint-stock) pharmaceutical company was born to overcome the lack of high-tech medicines in the local market. This was chased by importing high-quality products from well-reputed global pharmaceutical manufacturers and suppliers. Given that the pharmaceutical market is quite challenging due to its very competitive nature, the founders employed a team of professionals with decades of international pharmaceutical business experience to lead Nikan.
Infant Formulas
Following its establishment, to meet its local healthcare obligations, Nikan promptly partnered with some multinational companies in Europe to import infant formulas. Due to increasing demand and shortage of supply, regular and special infant formulas were quickly imported making Nikan one of the leading suppliers in this sector.
Parenteral Products
The COVID-19 outbreak and a tremendous upsurge in the consumption of large-volume parenteral products such as normal saline, dextrose-saline, and other similar agents, imposed an inevitable shift in import strategy on Nikan. This led to a strong partnership with one of the world’s most renowned manufacturers of parenteral products and a major step forward for Nikan in further establishing itself as a major player in the Parenteral market.
Niche Pharmaceuticals
Niche pharmaceuticals such as anticancer agents, immunosuppressants, and drugs for special diseases have always had a steady marketplace globally. After realizing this in the local market following a systematic survey, Nikan management decided to import these drugs from well-reputed international suppliers to meet the patient’s therapeutic needs. Hence, therapeutic choices for Cystic Fibrosis and some cancers were put on the agenda for import.
Human Plasma
After attaining solid success in the import of essential pharmaceutical products and touching a decent growth rate, the company decided to expand its activities to a relatively new segment. By kicking off its first plasma donation center with a 20000 liter/annum capacity in one of Iran’s main industrial cities to collect human plasma from eligible healthy donors, Nikan officially entered the human plasma industry. This was made possible mainly because of the presence of a highly talented professional team with immense experience in the field of plasmapheresis.
Manufacturing
Under-license manufacturing of branded pharmaceutical products is the company's latest accomplishment, which was made possible by the extensive collaboration of its European partners as well as local contract manufacturing plants. With this move, Nikan Pharmed took a major step in joining the already competitive local manufacturing sector by offering high-quality food supplements, foods for special medical purposes (FSMPs), and some medical devices.
Adverse Drug Reactions
Have you used any of our products and experienced adverse reactions?
If the answer is yes, then please contact us using one of the options below.
We will make sure our pharmacovigilance
experts reach out to you
and provide necessary assistance
about any issues pertaining
to
the use of our products.
You may also fill in the ADR Report form
so that we can assist you better with
your problem :